| Level of ETB receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules. | |
| | |
MedLine Citation:
|
PMID: 1321607 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Using ROS17/2 rat osteosarcoma cells as a model system, we examined the possibility that endothelin (ET)-induced down-regulation of ETB receptor was accompanied by a decrease in levels of ETB receptor mRNA. Northern blot analysis showed that low doses of ET-1 and ET-3 caused a transient decrease in ETB receptor mRNA in the cells. The maximum decrease in the levels of ETB receptor mRNA (80%) occurred after 2-4 h of exposure of the cells to ETs and was followed by a gradual recovery to control levels by 24 h. The effects were dose-dependent (EC50-1 nM), and ET-1 and ET-3 were almost equipotent in eliciting the response. The addition of either ionomycin, a Ca2+ ionophore, or phorbol dibutyrate, a protein kinase C activator, mimicked the effect of ETs. These results suggested that ETs-induced down-regulation of ETB receptor mRNA was mediated by the activation of ETB receptor and that it may have involved ETB receptor coupled second messenger pathways. We also showed that ETB receptor mRNA had a long intracellular life span which suggested that ETs-induced down-regulation of ETB receptor mRNA may have been due to a decrease in the stability of mRNA, rather than inactivation of the transcription of mRNA. |
| | |
Authors:
|
T Sakurai; H Morimoto; Y Kasuya; Y Takuwa; H Nakauchi; T Masaki; K Goto |
Related Documents
:
|
15977967 - Drug treatment of pulmonary arterial hypertension: current and future agents. 21321127 - Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction... 11787467 - Positive inotropic responses mediated by endothelin et(a) and et(b) receptors in human ... 8119297 - Identification of a ligand-binding site of the human endothelin-a receptor and specific... 8971347 - The molecular genetics of retinoic acid receptors: cardiovascular and limb development. 9602087 - Differences in d2 dopamine receptor binding in the neostriatum between cats hemidecorti... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Biochemical and biophysical research communications Volume: 186 ISSN: 0006-291X ISO Abbreviation: Biochem. Biophys. Res. Commun. Publication Date: 1992 Jul |
Date Detail:
|
Created Date: 1992-08-14 Completed Date: 1992-08-14 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0372516 Medline TA: Biochem Biophys Res Commun Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 342-7 Citation Subset: IM |
Affiliation:
|
Institute of Basic Medical Sciences, University of Tsukuba, Ibaraki, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blotting, Northern Cell Line Endothelins / metabolism, pharmacology* Gene Expression Regulation, Neoplastic / drug effects Ionomycin / pharmacology Kinetics Osteosarcoma Phorbol 12,13-Dibutyrate / pharmacology RNA, Messenger / isolation & purification, metabolism* RNA, Neoplasm / genetics, isolation & purification Rats Receptors, Cell Surface / genetics* Receptors, Endothelin |
| Chemical | |
Reg. No./Substance:
|
0/Endothelins; 0/RNA, Messenger; 0/RNA, Neoplasm; 0/Receptors, Cell Surface; 0/Receptors, Endothelin; 37558-16-0/Phorbol 12,13-Dibutyrate; 56092-81-0/Ionomycin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: cAMP-regulated chloride currents in CHO cells.
Next Document: Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminog...